We are constantly seeking out strategic partnerships with companies and research institutions that complement SOM Biotech’s discovery and development expertise. SOM Biotech business model is based in out licensing its own programs and establishing partnership agreements for the development of repositioned drugs. In licensing opportunities to enrich our research pipeline are also being assessed.


Early asset licensing before Clinical PoC or Late licensing after Clinical PoC.


Co-development agreements: Pharma/Biotech companies or public institutions interested in finding new indications for a specific drug/identifying marketed drugs for a specific disease.


Pre-Clinical and Early Clinical Stage programs for medical unmet needs.

We welcome inquiries from biopharmaceutical companies/research institutions wishing to discuss potential collaborations with us. Partnerships are an important part of SOM Biotech’s growth strategy.

To inquire about partnering opportunities with SOM Biotech, please send an email to our business development team

Partially some of our projects are funded by public grants. For more information click here (page in Spanish).